MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 199 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 1.76 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $409 | -36.8% | 2,800 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $647 | -29.8% | 2,800 | -26.3% | 0.00% | -40.0% |
| Q1 2023 | $921 | -16.5% | 3,800 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $1,103 | -99.6% | 3,800 | 0.0% | 0.01% | +250.0% |
| Q3 2022 | $247,000 | -9.2% | 3,800 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $272,000 | -27.1% | 3,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $373,000 | +15.8% | 3,800 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $322,000 | +49.8% | 3,800 | +40.7% | 0.00% | +100.0% |
| Q3 2021 | $215,000 | -18.3% | 2,700 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $263,000 | -6.4% | 2,700 | +12.5% | 0.00% | -50.0% |
| Q1 2021 | $281,000 | +5.2% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $267,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |